Hunan Tankang to develop “artificial carbon fibre bone”

Hunan Tankang Biotechnology Co., Ltd. (Hunan Tankang) focuses on the research, development, production and sales of carbon-based biomaterials. Its main product – artificial carbon fibre composite bone – is the third generation of advanced medical biomaterials. After 12 years of special research, the company has original special preparation technologies for carbon-based medical materials, including carbon fibre modification, composite weaving, 3D profiling, CVD gradient, carbon surface treatment. carbon, etc. It has successfully obtained 31 patent authorizations and published 12 papers and was included in the breakthrough technology base of the Ministry of Science and Technology in 2021.

This year’s Hunan Tankang “Artificial Carbon Fibre Bone” project claims to be the first of its kind in the world, filling the gap in the global application of carbon fibre in the field of artificial bone. It obtained special approval from National Innovative Medical Devices in 2023 and has been used in Xiangya Second Hospital, Jiangxi Provincial People’s Hospital, Hunan Provincial Traditional Chinese Medicine Hospital and other successful clinical trials .

Accrording to Hunan Tankang, compared with traditional materials such as titanium alloys, artificial carbon fibre bone products have obvious advantages. They can effectively solve six major medical problems such as human body rejection, osteogenesis, super large wound repair, complex wound repair, medical artifacts, and secondary injuries due to brittle fracture.